Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
22.16
+6.42 (40.79%)
At close: Mar 9, 2026, 4:00 PM EDT
22.03
-0.13 (-0.59%)
After-hours: Mar 9, 2026, 6:26 PM EDT

Company Description

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.

The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers.

Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.

Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.

The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc.
Hims & Hers Health logo
Country United States
Founded 2017
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,442
CEO Andrew Dudum

Contact Details

Address:
2269 Chestnut Street, Suite 523
San Francisco, California 94123
United States
Phone 415 851 0195
Website hims.com

Stock Details

Ticker Symbol HIMS
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001773751
CUSIP Number 433000106
ISIN Number US4330001060
SIC Code 8011

Key Executives

Name Position
Andrew Dudum Co-Founder, Chairman and Chief Executive Officer
Oluyemi Okupe Chief Financial Officer
Mike Chi Chief Operating Officer
Soleil Teubner Boughton J.D. Chief Legal Officer and Corporate Secretary
Dr. Patrick Carroll M.D. Chief Medical Officer and Director
Deborah M. Autor J.D. Chief Policy Officer and Director
Irene A. Becklund Senior Vice President, Controller and Principal Accounting Officer
Mohamed ElShenawy Chief Technology Officer
Dr. Peter Stahl M.D. Senior Vice President of Men's Reproductive and Sexual Health
Dr. Daniel Lieberman M.D. Senior Vice President of Mental Health

Latest SEC Filings

Date Type Title
Mar 5, 2026 SCHEDULE 13G/A Filing
Feb 27, 2026 144 Filing
Feb 24, 2026 S-8 Securities to be offered to employees in employee benefit plans
Feb 23, 2026 10-K Annual Report
Feb 23, 2026 8-K Current Report
Feb 19, 2026 8-K Current Report
Feb 13, 2026 SCHEDULE 13G/A Filing
Jan 20, 2026 144 Filing
Dec 22, 2025 144 Filing
Dec 17, 2025 144 Filing